Finch Therapeutics Group, Inc.
FNCHDelisted Oct 31, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001733257
Finch Therapeutics Group, Inc. was delisted on Oct 31, 2024; its insiders filed their last Form 4 on Jun 10, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Finch Therapeutics Group, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 47 | 43 | −4 |
| Shares | 9.86M | 10.0M | +178.4K (+1.8%) |
| Value | $28.0M | $16.8M | −$11.2M (−40.1%) |
New holders (4)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Boston Private Wealth LLC | 253,054 | $423.0K | 0.01% |
| Virtu Financial LLC | 15,190 | $25.0K | 0.00% |
| Dimensional Fund Advisors LP | 10,037 | $17.0K | 0.00% |
| Royal Bank of Canada | 160 | $0 | 0.00% |
Sold out (8)
Institutions that held Finch Therapeutics Group, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ergoteles LLC | 36,600 | $104.0K |
| Citadel Advisors LLC | 24,778 | $70.0K |
| Captrust Financial Advisors | 3,175 | $9.00K |
| Tower Research Capital LLC (TRC) | 337 | $1.00K |
| New York State Common Retirement Fund | 76 | $0 |
| Credit Suisse AG | 4 | $0 |
| Citigroup Inc | 49 | $0 |
| Capital Advisors, Ltd. LLC | 63 | $0 |